Eco-conscious AQbD-guided stability-indicating RP-UPLC method for analysing Tovorafenib in bulk and dosage forms
Vanga Mohan Goud1, Sarad Pawar Naik Bukke2, Praveen Kumar Kusuma3
1Department of Pharmaceutical Analysis, Joginpally BR Pharmacy College, Telangana, 500075, Hyderabad, India.
Abstract:
Tovorafenib is a type II RAF inhibitor recently approved by the FDA for relapsed or refractory paediatric low-grade glioma in children aged 6 months and older with BRAF fusions or V600E mutations, owing to its strong central nervous system penetration and absence of paradoxical MAPK pathway activation observed with type I inhibitors. This study developed and validated a fast, robust, and environmentally friendly reversed-phase ultra-performance liquid chromatography method for Tovorafenib quantification, employing ICH Q14 development, ICH Q2(R1) validation, and assimilating Analytical Quality by Design and green analytical chemistry principles. Chromatographic analysis was performed using a Waters Acquity UPLC BEH C18 column and 0.01 N Na₂HPO₄ in water: methanol (62:38 v/v) as the mobile phase at 0.29 ml/min, with PDA detection at 292 nm. The optimized approach exhibited excellent linearity (r² = 0.9997) and reproducibility (low %RSD). Forced degradation studies demonstrated Tovorafenib stability under most conditions, except during acid hydrolysis. Assessment with green chemistry tools yielded favourable eco-scores (ComplexMoGAPI 90, AGREE 0.61, BAGI 70, RAPI 92.5, EVG Q2, and RGBfast 97.5%). This validated RP-UPLC procedure offers reliable, sensitive, and sustainable Tovorafenib analysis, supporting both efficient pharmaceutical quality control and environmental sustainability.
Insights
A new, eco-friendly liquid chromatography method quantifies Tovorafenib, an important drug for pediatric low-grade glioma. This validated method ensures accurate drug analysis for quality control and environmental sustainability.
Area of Science:
- Analytical Chemistry
- Pharmaceutical Science
- Green Chemistry
Background:
- Tovorafenib, a type II RAF inhibitor, is FDA-approved for pediatric low-grade glioma with specific BRAF alterations.
- It offers advantages over type I inhibitors due to CNS penetration and lack of paradoxical MAPK activation.
Purpose of the Study:
- To develop and validate a rapid, robust, and green reversed-phase ultra-performance liquid chromatography (RP-UPLC) method for Tovorafenib quantification.
- To align method development with ICH Q14 and validation with ICH Q2(R1) guidelines, incorporating Analytical Quality by Design (AQbD) and green analytical chemistry principles.
Main Methods:
- Utilized a Waters Acquity UPLC BEH C18 column with a specific mobile phase (water:methanol, 62:38 v/v) and PDA detection at 292 nm.
- Employed ICH Q14 for development and ICH Q2(R1) for validation, including linearity, reproducibility, and forced degradation studies.
- Assessed environmental impact using various green chemistry metrics (e.g., ComplexMoGAPI, AGREE, RAPI).
Main Results:
- The method demonstrated excellent linearity (r² = 0.9997) and reproducibility (low %RSD).
- Tovorafenib showed stability under most forced degradation conditions, with sensitivity to acid hydrolysis.
- Favorable eco-scores were obtained, indicating a sustainable analytical approach.
Conclusions:
- The validated RP-UPLC method provides a reliable, sensitive, and sustainable means for Tovorafenib analysis.
- This approach supports efficient pharmaceutical quality control while adhering to environmental sustainability principles.
- The study highlights the successful integration of AQbD and green chemistry in analytical method development.
More Related Videos
10:24Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus
Published on: April 19, 2024
10:22Improved UPLC-UV Method for the Quantification of Vitamin C in Lettuce Varieties Lactuca sativa L. and Crop Wild Relatives Lactuca spp.
Published on: June 30, 2020
Related Concept Videos
Therapeutic Drug Monitoring: Drug Analysis Methods
Measurement of Bioavailability: Pharmacodynamic Methods
Measurement of Bioavailability: Pharmacokinetic Methods
Drug Product Performance: In Vitro–In Vivo Correlation
Clinically Relevant Drug Product Specifications: Methods of Establishment
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
